Diminished Ovarian Reserve Clinical Trial
Official title:
Study of Ovarian Function Following Intraovarian Injection of Platelet Rich Plasma (PRP) In Women With Evidence of Diminished Ovarian Function
The hypothesis of the study is that ovaries of women with a history of poor response to ovulation induction may benefit from exposure to growth factors known to be present in Platelet Rich Plasma (PRP). Since even ovaries from women with poor response still contain primordial follicles (which, however, no longer undergo recruitment), it is hoped that PRP injections into ovaries will activate follicular recruitment pathways and, subsequently, result in follicle growth. Should such growth be observed, follicles will be supported with routine daily gonadotropin stimulation until hCG trigger.
The hypothesis of the study is that ovaries of women with a history of poor response to ovulation induction may benefit from exposure to growth factors known to be present in PRP. Autologous Platelet Rich Plasma (A-PRP) is plasma with a concentration of platelets above the blood baseline. A-PRP is developed from autologous blood. Within A-PRP, the concentration of platelets delivers an increased number of growth factors. In this study A-PRP will be prepared using Regen Lab PRP Kit which is approved by US-FDA for preparation of PRP. PRP is becoming widely used in a variety of medical procedures seeking tissue remodeling and/or healing as an intervention. To date, applications in orthopedics, wound healing, dermatology and plastic surgery have gained general acceptance, primarily as the role of platelets and their activation in tissue repair and recovery has become better understood at a cellular and molecular level. This knowledge base provides a foundation for the present study because of the ready availability of FDA-approved kits for autologous PRP preparations and the recognition that the aging ovary acquires tissue pathologies in the form of wound healing and fibrosis as a result of repeat ovulations over the reproductive lifespan of women. Since PRP is an autologous blood product, and is widely used via injection into various organs and tissues, safety concerns are minimal. This study will involve only adult women with a diagnosis of diminished ovarian reserve. All consenting participants will receive injections of autologous Platelet RIch Plasma (A-PRP) in both ovaries under ultrasound guidance performed after induction of IV sedation. Assumption of this study is that in women with previous poor response to ovulation induction will show limited follicle growth. The study will try to estimate effect of PRP on this condition by comparing post-PRP response to the previous response. The investigators recognize that there will be a possibility of apparent response based on regression to the mean. The investigators expect that study of fifty patients should be enough to determine if there is a potential clinical effect and to allow estimation of that effect for power calculations for future studies. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04972877 -
Effect of Electro-acupuncture on Women With Diminished Ovarian Reserve
|
N/A | |
Recruiting |
NCT04447872 -
The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol
|
N/A | |
Recruiting |
NCT05277948 -
Effect of Thumbtack Needle on Ovarian Function of Women With Diminished Ovarian Reserve (DOR)
|
N/A | |
Recruiting |
NCT04711772 -
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve
|
||
Recruiting |
NCT03670407 -
Follicular Activation by Fragmentation of Ovarian Tissue
|
N/A | |
Recruiting |
NCT06072794 -
A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI)
|
Phase 1 | |
Recruiting |
NCT06096766 -
the Correlation Between Ovarian Function and Serum Biomarkers
|
||
Not yet recruiting |
NCT02099916 -
Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06081257 -
The Effect of "KB-120" Small Molecular Nutrient in Women With Decreased Ovarian Reserve
|
N/A | |
Recruiting |
NCT06426355 -
The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR
|
N/A | |
Recruiting |
NCT06223178 -
Efficacy of Thumb-tack Needle Treatment for Diminished Ovarian Reserve
|
N/A | |
Not yet recruiting |
NCT05577455 -
Efficacy of Traditional Chinese Medicine on Ameliorating IVF-ET Outcomes of Diminished Ovarian Reserve Patients
|
Phase 3 | |
Not yet recruiting |
NCT05459493 -
A Clinical Study of Chinese Herbal Compound TJAOA101 in Therapy of Diminished Ovarian Reserve
|
Early Phase 1 | |
Recruiting |
NCT05665010 -
Precise Stratification of Genetic Risk of Ovarian Function Impairment
|
||
Not yet recruiting |
NCT05385848 -
Autologous Platelet-rich Plasma (PRP) Infusion to Improve Outcomes in Women With Ovarian Insufficiency: a Pilot Study
|
N/A | |
Terminated |
NCT01614067 -
Delayed Start to Ovarian Stimulation
|
Phase 4 | |
Recruiting |
NCT06395623 -
Study of Acupoints in Diminished Ovarian Reserve Based on Biological Characteristics
|
||
Recruiting |
NCT05847283 -
DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT
|
N/A | |
Recruiting |
NCT05485610 -
Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)
|
N/A | |
Completed |
NCT04237909 -
Effects of Intraovarian Platelet Rich Plasma in Women With Poor Ovarian Response and Premature Ovarian Insufficiency
|
N/A |